Ticker >

Indrayani Biotech share price

Indrayani Biotech Ltd.

BSE: 526445 SECTOR: Floriculture  12k   34   1

59.79
+0.47 (0.79%)
BSE: 18 Apr 04:01 PM

Price Summary

Today's High

₹ 60.95

Today's Low

₹ 58.6

52 Week High

₹ 99.7

52 Week Low

₹ 46.8

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

272.26 Cr.

Enterprise Value

306.91 Cr.

No. of Shares

4.55 Cr.

P/E

120.57

P/B

4.64

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  12.89

CASH

0.62 Cr.

DEBT

35.27 Cr.

Promoter Holding

42.13 %

EPS (TTM)

₹  0.5

Sales Growth

28.44%

ROE

15.67 %

ROCE

12.45%

Profit Growth

19.67 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year28.44%
3 Year429.45%
5 Year∞%

Profit Growth

1 Year19.67%
3 Year198.53%
5 Year111.96%

ROE%

1 Year15.67%
3 Year-26.41%
5 Year-15.85%

ROCE %

1 Year12.45%
3 Year-7.39%
5 Year-4.43%

Debt/Equity

0.7111

Price to Cash Flow

32.68

Interest Cover Ratio

2.78296124684077

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 42.13 14.98
Dec 2023 33.63 0
Sep 2023 44.84 0
Jun 2023 44.89 0
Mar 2023 44.89 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 429.452836963% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 43.977784496118 days.

 Limitations

  • Company has a poor ROE of -26.4116077206755% over the past 3 years.
  • Promoter pledging has increased from 0% to 14.98% in 1 quarter.
  • Company has a poor ROCE of -7.38678301247287% over the past 3 years
  • The company has a low EBITDA margin of -6.11786929685576% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 45.1914.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 21.66 21.31 16.82 16.01 13.69
Total Expenditure 19.02 18.86 14.79 14.71 12.36
Operating Profit 2.63 2.45 2.03 1.3 1.33
Other Income 0.05 0.15 0.01 0.09 0.08
Interest 0.58 1.24 0.96 0.62 0.78
Depreciation 0.18 0.48 0.36 0.37 0.37
Exceptional Items -0.25 0 0 0 0
Profit Before Tax 1.67 0.87 0.72 0.41 0.26
Tax 0 0 0 0 0
Profit After Tax 1.67 0.87 0.72 0.41 0.26
Adjusted EPS (Rs) 0.49 0.25 0.21 0.12 0.06

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 0 0.5 21.01 57.99 74.48
Total Expenditure 0.21 0.66 25.68 51.75 65.76
Operating Profit -0.21 -0.15 -4.67 6.24 8.72
Other Income 0.16 0 0.26 0.22 0.64
Interest 0 0.05 1.97 1.89 2.85
Depreciation 0 0 0.4 0.34 0.93
Exceptional Items 0 0 -4.11 0 -0.5
Profit Before Tax -0.05 -0.21 -10.89 4.23 5.08
Tax 0 0 0 0 0.02
Net Profit -0.05 -0.21 -10.89 4.23 5.06
Adjusted EPS (Rs.) -0.15 -0.56 -3.18 1.23 1.48

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 3.64 3.64 34.23 34.23 43.48
Total Reserves -4.3 -4.5 -14.28 -10.05 7.67
Borrowings 0.64 0.69 8.15 6.79 9.76
Other N/C liabilities 0 0 0.01 0.01 6.33
Current liabilities 0.02 0.39 11.73 18.46 33.06
Total Liabilities 0.01 0.22 39.85 49.43 100.3
Assets
Net Block 0 0 15.11 15.33 23.81
Capital WIP 0 0 13.72 13.22 12.72
Intangible WIP 0 0 0 0 0
Investments 0 0 0.19 0.19 7.99
Loans & Advances 0 0 0.47 2.03 6.46
Other N/C Assets 0 0 1.33 0.68 0
Current Assets 0.01 0.22 9.04 17.99 49.33
Total Assets 0.01 0.22 39.85 49.43 100.3
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -0.05 -0.21 -10.89 4.23 5.06
Adjustment -0.16 0.05 4.47 2.21 4.18
Changes in Assets & Liabilities 0.01 0.23 6.94 -2.97 -0.91
Tax Paid 0 0 0 0 0
Operating Cash Flow -0.21 0.08 0.52 3.47 8.33
Investing Cash Flow 0 0 -0.56 0.59 -14.09
Financing Cash Flow 0.2 0 -0.73 -3.23 4.93
Net Cash Flow 0 0.08 -0.78 0.82 -0.83

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 44.89 44.89 44.84 33.63 42.13
g swaminathan . - 12.10 - - 11.41
i umasundari . - 6.13 - - 5.78
jothi ramesh . - 3.07 - - 2.89
m ramesh . - 3.07 - - 2.89
s i dinesh kumar . - 2.05 - - 1.93
s indirakumar . - 6.13 - - 5.78
sayee sundar kasiraman 7.69 7.69 7.69 5.78 7.25
thirumeni thiruselvaraja ... - 2.61 - - 2.33
v agathiyan . - 2.05 - - 1.85
g swaminathan 12.10 - 12.10 9.09 -
i umasundari 6.13 - 6.13 4.61 -
jothi ramesh 3.07 - 3.07 2.31 -
m ramesh 3.07 - 3.07 2.31 -
s i dinesh kumar 2.05 - 2.05 1.54 -
s indirakumar 6.13 - 6.13 4.61 -
thirumeni thiruselvaraja 2.61 - 2.56 1.88 -
v agathiyan 2.05 - 2.05 1.50 -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 55.11 55.11 55.16 66.37 57.87
ajitkumar c patel 3.21 3.21 3.21 - 3.03
llp 0.15 0.13 0.13 0.21 0.13
malarvannan subashini - - - - 2.92
next orbit ventures fund 15.56 15.27 13.11 7.58 8.47
r raja . - 3.16 3.16 - 2.98
s prakash - - - - 2.14
sridhar - - - - 2.76
bougainvillea investments... 3.50 3.45 1.84 1.32 -
india equity fund 1 1.46 - - - -
r raja 3.16 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Indrayani Biotech informs about disclosure19 Feb 2024, 3:27PM Indrayani Biotech informs about newspaper publications14 Feb 2024, 11:51AM Indrayani Biotech - Quaterly Results10 Feb 2024, 9:59PM Indrayani Biotech informs about clarification22 Jan 2024, 12:19PM Indrayani Biotech informs about newspaper advertisement17 Jan 2024, 3:20PM Indrayani Biotech informs about loss of share certificate2 Dec 2023, 2:31PM Indrayani Biotech informs about loss of share certificate2 Dec 2023, 2:17PM Indrayani Biotech’s arm disinvests 51% stake in India Home Health Care30 Aug 2023, 5:15PM Indrayani Biotech’s arm invests in Kniss Laboratories26 Aug 2023, 12:57PM Indrayani Biotech - Quaterly Results11 Aug 2023, 9:40PM Indrayani Biotech informs about outcome of the board meeting15 Jun 2023, 10:05AM Indrayani Biotech - Quaterly Results15 Jun 2023, 12:04AM Indrayani Biotech - Quaterly Results15 Jun 2023, 12:04AM Indrayani Biotech - Quaterly Results15 Jun 2023, 12:04AM Indrayani Biotech informs about board meeting 7 Jun 2023, 4:58PM Indrayani Biotech informs about certificate28 Apr 2023, 12:12PM Indrayani Biotech’s arm to invest in Kniss Laboratories 14 Apr 2023, 9:35AM Indrayani Biotech informs about certificate7 Jan 2023, 3:29PM Indrayani Biotech’s food and hospitality division bags order from Gautam Buddha University3 Jan 2023, 2:06PM Indrayani Biotech’s arm acquires 51% stake in HIPL8 Dec 2022, 10:36AM Indrayani Biotech informs about loss of share certificate26 Nov 2022, 12:22PM Indrayani Biotech’s arm acquires 51% stake in IHHCPL24 Nov 2022, 10:57AM Indrayani Biotech acquires 51% stake in Matrix Boilers15 Nov 2022, 9:46AM Indrayani Biotech - Quaterly Results14 Nov 2022, 12:00PM Indrayani Biotech informs about certificate11 Oct 2022, 4:52PM Indrayani Biotech’s Food and Hospitality division bags order from Indian Institute of Technology20 Aug 2022, 10:30AM Indrayani Biotech enters into MoU with Dindigul Farm Product20 May 2022, 9:52AM Indrayani Biotech informs about disclosure17 May 2022, 11:02AM Indrayani Biotech informs about updates15 Mar 2022, 4:50PM Indrayani Biotech commences operations of Boiler division in association with Matrix Boilers15 Mar 2022, 3:59PM Indrayani Biotech informs about closure of trading window7 Jul 2021, 12:56PM Indrayani Biotech informs about price verification letter3 Jun 2021, 3:15PM Indrayani Biotech incorporates WOS company2 Nov 2020, 9:52AM Indrayani Biotech - Quaterly Results29 Aug 2020, 5:26PM Indrayani Biotech informs about confirmation certificate23 Jul 2020, 4:00PM

Indrayani Biotech Stock Price Analysis and Quick Research Report. Is Indrayani Biotech an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Indrayani Biotech has a PE ratio of 120.568663036903 which is high and comparatively overvalued .

  • Share Price: - The current share price of Indrayani Biotech is Rs 59.79. One can use valuation calculators of ticker to know if Indrayani Biotech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Indrayani Biotech has ROA of 6.75446798279593 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Indrayani Biotech has a Current ratio of 1.49221545656113 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Indrayani Biotech has a ROE of 15.672710367271 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Indrayani Biotech has a D/E ratio of 0.7111 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Indrayani Biotech has an Inventory turnover ratio of 46.1178947368421 which shows that the management is efficient in relation to its Inventory and working capital management.

  • Sales growth: - Indrayani Biotech has reported revenue growth of 28.4399493002923 % which is fair in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Indrayani Biotech for the current financial year is 11.7061669915844 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Indrayani Biotech is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Indrayani Biotech
X